HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kei Kurokawa Selected Research

Neoplasms (Cancer)

11/2003Establishment and characterization of mouse mammary carcinoma cell lines expressing RET with a multiple endocrine neoplasia 2A mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kei Kurokawa Research Topics

Disease

2Multiple Endocrine Neoplasia Type 2a (MEN 2)
05/2010 - 09/2002
2Neuroblastoma
05/2010 - 08/2006
1Hyperplasia
08/2021
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
08/2021
1Papillary Thyroid Cancer
05/2010
1Neoplasms (Cancer)
11/2003
1Multiple Endocrine Neoplasia Type 2b (MEN 3)
09/2002
1Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
09/2002

Drug/Important Bio-Agent (IBA)

2Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
05/2010 - 08/2006
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2010
1platelet protein P47 (pleckstrin)IBA
05/2010
1Small Interfering RNA (siRNA)IBA
08/2006
1Caspase 6IBA
11/2003
1Aldo-Keto ReductasesIBA
11/2003
1ThymosinIBA
11/2003
1Type 4 Fibroblast Growth Factor ReceptorIBA
11/2003
1Mutant Proteins (Protein, Mutant)IBA
09/2002

Therapy/Procedure

1Adjuvant Chemotherapy
08/2021
1Transurethral Resection of Prostate (TURP)
08/2021
1Drug Therapy (Chemotherapy)
08/2021